Progyny (NASDAQ: PGNY) revenue
Progyny reported revenue of $1,289m for fiscal 2025, 10.4% more than in fiscal 2024 ($1,167m). Since fiscal 2018 its revenue has grown by 1,122.6%, an average growth of 43.0% a year.
Progyny has grown its revenue for 7 years in a row, and fiscal 2025 is the highest of its 8 fiscal years on record.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $1,289m | +10.4% | $85.3m | 6.6% |
| 2024 | $1,167m | +7.2% | $67.5m | 5.8% |
| 2023 | $1,089m | +38.3% | $62.2m | 5.7% |
| 2022 | $786.9m | +57.2% | $23.3m | 3.0% |
| 2021 | $500.6m | +45.2% | $32.3m | 6.5% |
| 2020 | $344.9m | +50.1% | $8.3m | 2.4% |
| 2019 | $229.7m | +117.9% | $9.7m | 4.2% |
| 2018 | $105.4m | — | −$3.5m | −3.3% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Progyny revenue compared with its sector
By revenue for its latest fiscal year, Progyny ranks 136th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Progyny, 10.4%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 134th | Haemonetics | $1,334m | −2.0% |
| 135th | HealthEquity | $1,313m | 9.5% |
| 136th | Progyny | $1,289m | 10.4% |
| 137th | Tempus AI | $1,272m | 83.4% |
| 138th | Indivior Pharmaceuticals | $1,239m | 4.3% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Progyny
- How much revenue did Progyny make in fiscal 2025?
- Progyny reported revenue of $1,289m for fiscal 2025, compared with $1,167m in fiscal 2024.
- How much has the revenue of Progyny grown?
- Between fiscal 2018 and fiscal 2025 it went from $105.4m to $1,289m: 1,122.6% more, an average growth of 43.0% a year.
- What was the best year for revenue at Progyny?
- Of its last 8 fiscal years, fiscal 2025, with $1,289m.
- Where does Progyny rank in its sector by revenue?
- It ranks 136th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Progyny come from?
- From the annual report (Form 10-K) that Progyny files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Progyny files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018. More on Progyny: the Progyny page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.